Prolactin is known to have renal sodium retention properties in animal
s. In man, only two studies have suggested a similar effect in healthy
volunteers or in patients with microprolactinoma. Since hyperprolacti
nemia is frequently observed in liver disease, this prospective study
of 19 patients evaluated the influence of prolactin on urinary electro
lytes excretion in cirrhosis. Basal hyperprolactinemia was found in 14
out of 19 cases. The effect of serum prolactin elevation on renal sod
ium and potassium excretion was studied in all patients after thyrotro
pin-releasing hormone stimulation (200 mu g), with seven consecutive h
ourly urinary samples. Patients were separated into two groups accordi
ng to amount of prolactin discharge after thyrotropin-releasing hormon
e injection. Group I included patients with ''low prolactin release'',
defined as the difference between basal and peak prolactin values (De
lta prolactin)<1000 mu u/ml (n=8), and no change in natriuresis could
be observed. In contrast, in group II with a ''high PRL release'' (Del
ta prolactin>1000 mu u/ml, n=11), significant reductions in urinary so
dium (p<0.01) and potassium (p<0.02) excretion were observed, which la
sted until the third hour after thyrotropin-releasing hormone injectio
n. A significant correlation was found between peak prolactin values a
nd the decrements of natriuresis (r=0.70, p<0.02). The pattern of urin
ary electrolyte changes and the stability of the ratio U-K/U-K+Na sugg
est a possible sodium-retaining effect of prolactin localized proximal
ly to the distal tubule. (C) Journal of Hepatology.